Indeed, G2019S-LRRK2 PD patients fibroblasts showed several morphological abnormalities in mitochondria [63], and in SH-SY5Y cells, the overexpression of WT-LRRK2 produced mitochondrial fragmentation exacerbated by G2019S mutation [64]. This evidence concerns the gene LRRK2 and Parkinson disease.